Allograft osteochondral plug combined with cartilage particle mixture

• US 20090291112A1
• Filed: 02/09/2009
• Published: 11/26/2009
• Est. Priority Date: 05/16/2003
• Status: Abandoned Application

• Current Assignee: Musculoskeletal Transplant Foundation
• Original Assignee: Musculoskeletal Transplant Foundation
• Inventors: Huang, Yen-Chen, Yannariello-Brown, Judith I., Tomford, William W., Sunwoo, Moon Hae, Truncale, Katherine G., Gertzman, Arthur A.
• Application Number:
  US12/322,996
• Publication Number:
  US 20090291112A1
• Time in Patent Office: Days
• US Class Current: 424/423
• CPC Class Codes: A61F 2/28 Bones joints A61F2/30
• CPC Class Codes: A61F 2/30756 Cartilage endoprostheses A61F2/3603 takes precedence
• CPC Class Codes: A61F 2/3859 Femoral components
• CPC Class Codes: A61F 2002/2817 Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]
• CPC Class Codes: A61F 2002/2839 Bone plugs or bone graft dowels
• CPC Class Codes: A61F 2002/30004 the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis
• CPC Class Codes: A61F 2002/30062 (bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
• CPC Class Codes: A61F 2002/30136 undulated or wavy, e.g. serpentine-shaped or zigzag-shaped
• CPC Class Codes: A61F 2002/30224 cylindrical
• CPC Class Codes: A61F 2002/30233 Stepped cylinders, i.e. having discrete diameter changes
• CPC Class Codes: A61F 2002/30235 tubular, e.g. sleeves
• CPC Class Codes: A61F 2002/30299 umbrella-shaped or mushroom-shaped
• CPC Class Codes: A61F 2002/30327 differing in diameter
• CPC Class Codes: A61F 2002/30764 Cartilage harvest sites
• CPC Class Codes: A61F 2002/30785 parallel
• CPC Class Codes: A61F 2002/4645 Devices for grinding or milling bone material
• CPC Class Codes: A61F 2210/0004 bioabsorbable
• CPC Class Codes: A61F 2230/0004 Rounded shapes, e.g. with rounded corners
• CPC Class Codes: A61F 2230/0069 cylindrical
• CPC Class Codes: A61F 2230/0093 Umbrella-shaped, e.g. mushroom-shaped
• CPC Class Codes: A61F 2250/0014 : having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
• CPC Class Codes: A61F 2250/0039 : differing in diameter
• CPC Class Codes: A61F 2310/00365 : Proteins; Polypeptides; Degradation products thereof
• CPC Class Codes: A61F 2310/00383 : Gelatin
• CPC Class Codes: A61L 2430/06 : for cartilage reconstruction, e.g. meniscus
• CPC Class Codes: A61L 27/3608 : Bone, e.g. demineralised bone matrix [DBM], bone powder
• CPC Class Codes: A61L 27/3612 : Cartilage, synovial fluid
• CPC Class Codes: A61L 27/3654 : Cartilage, e.g. meniscus
• CPC Class Codes: A61L 27/3804 : characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
• CPC Class Codes: A61L 27/48 : with macromolecular fillers
• CPC Class Codes: C08L 89/00 : Compositions of proteins; Compositions of derivatives thereof foodstuff preparations A23J3/00

Abstract

An allograft osteochondral plug is combined with a mixture that includes freeze-milled cartilage particles, and such combination is used to repair defects in articular cartilage. The plug includes an subchondral bone portion and an integral overlying cartilage cap which is treated to remove cellular debris and proteoglycans. At least a portion of the plug has a lateral dimension selected to form an interference fit against a tissue layer exposed as a result of a bore formed in a defect area in articular cartilage of a host. The cartilage particle mixture is placed adjacent at least a portion of the plug for promoting cartilage cell migration into (i.e., from the adjacent host cartilage) and proliferation in the bore, and for enhancing tissue integration between the plug and patient (i.e., host) tissue when the plug is inserted into the bore. Methods for surgical implantation of the plug into a patient are also disclosed.

Claims

1. In combination, a mixture including lyophilized, freeze-milled cartilage particles, at least a majority of which have a dimension, when dry, that does not exceed 212 microns;

and a sterile allograft osteochondral plug, said plug including a subchondral bone portion and an integral overlying cartilage cap which has been treated to remove cellular debris, chondrocytes and proteoglycans, at least a portion of said plug having a lateral dimension selected to form an interference fit against a tissue layer exposed as a result of a bore formed in a defect area in articular cartilage of a host, wherein said cartilage particle mixture is placed adjacent at least a portion of said plug for promoting cartilage cell migration into and proliferation in the bore and for enhancing tissue integration between said plug and host tissue, when said plug is inserted into the bore.

2. The combination as claimed in claim 1, wherein said dimension is in a range of from about 5 microns to about 212 microns.

3. The combination as claimed in claim 2, wherein said dimension is in a range of from about 6 microns to about 10 microns.

4. The combination as claimed in claim 1, wherein said dimension is less than or equal to about 5 microns.

5. The combination as claimed in claim 1, wherein said dimension is less than or equal to 100 microns.

6. The combination as claimed in claim 1, wherein said cartilage particles are derived from articular cartilage.

7. The combination as claimed in claim 1, wherein said cartilage particle mixture further comprises a chondrogenic stimulating factor.

8. The combination as claimed in claim 7, wherein said chondrogenic stimulating factor is one or more of a group consisting of growth factors, bioreactive peptides, recombinant, native growth factors, human allogenic or autologous chondrocytes, human allogenic or autologous bone marrow cells, stem cells, demineralized bone matrix, insulin, insulin-like growth factor-1, transforming growth factor-B, interleukin-1 receptor antagonist, hepatocyte growth factor, platelet-derived growth factor, Indian hedgehog and parathyroid hormone-related peptide or bioactive glue.

9. The combination as claimed in claim 8, wherein said growth factors are selected from a group consisting of FGF-2, FGF-5, FGF-7, FGF-9, FGF-11, FGF-21, IGF-1, TGF-β

, BMP-2, BMP-4, BMP-7, BMP-14, GDF-5, PDGF and VEGF.

10. The combination as claimed in claim 1, wherein said cartilage particle mixture further comprises a biocompatible carrier.

11. The combination as claimed in claim 9, wherein said biocompatible carrier comprises one or more of a group consisting of sodium hyaluronate, hyaluronic acid and its derivatives, gelatin, collagen, chitosan, alginate, buffered PBS, Dextran, polymers, Ringers, and synthetic and peptide based hydrogels.

12. The combination as claimed in claim 1, wherein said allograft osteochondral plug has been lyophilized so that its water content ranges from about 0.1% to about 8.0%.

13. The combination as claimed in claim 1, wherein said cartilage cap includes a first cap portion, which is located proximal to said subchondral bone portion of said plug, said first cap portion having a diameter the same as that of said subchondral bone portion of said plug, and a second cap portion, which is located remote from said subchondral bone portion of said plug, said second cap portion having a diameter less than that of said subchondral bone portion of said plug, said first and second cap portions being separated by an annular step which forms a ring-shaped gap positionable alongside a cartilage layer exposed as a result of the bore, said gap being sized and shaped so as to receive said cartilage particle mixture for promoting cartilage cell migration and proliferation in said gap and for enhancing tissue integration between said plug and host tissue, when said plug is inserted into the bore.

14. The combination as claimed in claim 13, wherein said first cap portion has a cylindrical shape, and said second cap portion has a cylindrical shape.

15. The combination as claimed in claim 13, wherein said first cap portion has a frustum conical shape and said second cap portion has a cylindrical shape.

16. The combination as claimed in claim 15, wherein said first cap portion includes a small diameter end positioned adjacent said second cap portion, and a large diameter end positioned adjacent said subchondral bone potion.

17. The combination as claimed in claim 13, wherein when said ring-shaped gap has a width in a range of from about 10 microns to about 1,000 microns.

18. The combination as claimed in claim 13, wherein when said ring-shaped gap has a width in a range of from about 100 microns to about 500 microns.

19. A method of repairing an articular cartilage defect of a patient, said method comprising the steps of:

providing a sterile allograft osteochondral plug, said plug including a subchondral bone portion and an integral overlying cartilage cap which has been treated to remove cellular debris, chondrocytes and proteoglycans;

forming a bore in an articular cartilage defect area of the patient, the bore exposing a subchondral bone layer and a cartilage layer in the defect area;

inserting a mixture into the bore, the mixture including lyophilized, freeze-milled cartilage particles, at least a majority of which have a dimension, when dry, that does not exceed 212 microns; and

inserting the plug into the bore so that at least a portion of the plug forms an interference fit against the exposed tissue of the patient, and at least a portion of the plug is adjacent the lyophilized, freeze-milled cartilage particle mixture, to promote cartilage cell migration into and proliferation in the bore and to enhance tissue integration between the plug and the patient'"'"'s tissue.

20. A method of producing a mixture including freeze-milled cartilage particles for the repair of articular cartilage defects, the method comprising the steps of:

recovering allograft cartilage tissue from a human donor;

treating the allograft cartilage tissue for bioburden reduction;

chemically cleaning the allograft cartilage tissue;

lyophilizing the allograft cartilage tissue;

freeze-milling the allograft cartilage tissue into particles;

sieving the freeze-milled cartilage particles through a 212 micron sieve, such that each of the freeze-milled cartilage particles has a dimension, when dry, that does not exceed 212 microns; and

combining the freeze-milled cartilage particles with a biocompatible carrier.